sparfloxacin has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blango, MG; Mulvey, MA | 1 |
| Ishii, N; Nakajima, H; Suga, C; Sugita, Y | 1 |
| Dorr, MB; Ellison, W; Henry, D; Magner, DJ; Mansfield, DL; Sullivan, J; Talbot, GH | 1 |
| Kumamoto, Y | 1 |
2 trial(s) available for sparfloxacin and Recrudescence
| Article | Year |
|---|---|
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urinary Tract Infections | 1998 |
Single-dose treatment of female acute uncomplicated cystitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols; Colony Count, Microbial; Cystitis; Fluoroquinolones; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urine | 1992 |
2 other study(ies) available for sparfloxacin and Recrudescence
| Article | Year |
|---|---|
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
A case of relapsed leprosy successfully treated with sparfloxacin.
Topics: Adult; Anti-Infective Agents; Fluoroquinolones; Humans; Leprosy, Lepromatous; Male; Quinolones; Recurrence; Remission Induction | 1996 |